Inovio Pharmaceuticals Inc (NASDAQ:INO)

7.92
Delayed Data
As of Jul 02
 -0.22 / -2.70%
Today’s Change
6.33
Today|||52-Week Range
14.20
-13.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$586.0M

Company Description

Inovio Pharmaceuticals, Inc. is revolutionizing the fight against cancer and infectious diseases. Its immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Contact Information

Inovio Pharmaceuticals, Inc.
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462
P:(267) 440-4200
Investor Relations:
(858) 410-3101

Employees

Shareholders

Individual stakeholders5.25%
Mutual fund holders16.91%
Other institutional15.42%

Top Executives

J. Joseph KimPresident, Chief Executive Officer & Director
Niranjan Y. SardesaiChief Operating Officer
Peter D. KiesChief Financial Officer
Jessica LeeVice President-Clinical Operations & Compliance
Mark L. BagarazziChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account